-
-
-
-
-
-
-
BofA Securities Upgrades PTC Therapeutics (PTCT) to Buy
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia
-
-
-
-
-
-
-
PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
-
-
-
-
-
-
-
Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Announces FDA Has Extended PDUFA Date for Risdiplam NDA to August 24
-
-
-
-
-
-
-
Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy
-
-
-
-
-
-
-
Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America
-
15,579 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

